Avidity’s AOCs technology represents a novel approach to RNA therapeutics
Avid Bioservices offers a wide range of services across the biopharmaceutical development
Aviceda’s lead product candidate, AVD−104, is being developed for the treatment of geographic atrophy (GA)
Aurinia’s lead product, Lupkynis® (voclosporin), is an oral medication approved for the treatment
ATTR amyloidosis is a rare, progressive disease caused by the accumulation of transthyretin protein
Atossa’s leading product candidate, Endoxifen, is an active metabolite of tamoxifen
AstraZeneca is renowned for its strong R&D capabilities: Global Research Network
Astellas Pharma US is at the forefront of oncology research, developing therapies for various types of cancer
The company utilizes advanced adenoassociated virus (AAV) vector technology for precise gene delivery
AskBio is developing gene therapies aimed at treating DMD, a severe genetic disorder characterized
Infectious Diseases: Hepatitis B and C: Ascletis has developed a comprehensive portfolio of therapies targeting hepatitis B and C
Clarivate provides comprehensive solutions for patent research,trademark protection
The Slate Rock Project is located in the Rainy River District of Ontario, a region known for its gold production
GoldMining Inc. adopts a prudent financial approach, utilizing various funding mechanisms to advance
The Athabasca Gold Project is one of Goldhills Holding’s flagship assets, located in Saskatchewan
Goldgroup Mining’s leadership team consists of experienced professionals with deep expertise
Goldex Resources is primarily focused on exploring gold and critical minerals in the Abitibi Greenstone Belt
The Pardoo Project is situated in an area with known gold mineralization, and previous exploration
Golden Share Resources is actively exploring its properties while managing financial risks
Golden Pursuit’s asset base consists of gold exploration properties, primarily located in Nevada
